Back to Search
Start Over
A Pilot Study Using Intratympanic Methylprednisolone for Treatment of Persistent Posterior Canal Benign Paroxysmal Positional Vertigo.
- Source :
-
The journal of international advanced otology [J Int Adv Otol] 2016 Dec; Vol. 12 (3), pp. 321-325. Date of Electronic Publication: 2016 Nov 28. - Publication Year :
- 2016
-
Abstract
- Objective: To assess the effect of intratympanic methylprednisolone (ITMP) in posterior canal benign paroxysmal positional vertigo (BPPV) that fails treatment involving repositioning maneuver in a case series.<br />Materials and Methods: Nine patients with persistent posterior canal BPPV after 6 or more repositioning maneuvers were treated by ITMP (two weekly doses of 0.3-0.4 mL at 40 mg/mL) before repeating the repositioning procedures.<br />Results: Following ITMP treatment, 7 out of 9 patients were relieved of their symptoms and did not exhibit positional nystagmus after 1 or 2 repositioning maneuvers. The number of positional maneuvers performed before and after ITMP treatment in these 7 patients showed a statistically significant (p=0.016) reduction in the amount of repositioning treatments required. None of the 7 respondent patients showed any relapses during the follow-up period (follow-up range: 11-95 months).<br />Conclusion: Administering ITMP before resuming repositioning procedures can be a useful treatment for persistent BPPV of the posterior canal.
Details
- Language :
- English
- ISSN :
- 1308-7649
- Volume :
- 12
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- The journal of international advanced otology
- Publication Type :
- Academic Journal
- Accession number :
- 27897129
- Full Text :
- https://doi.org/10.5152/iao.2016.3014